Article

Memory B cell Development in Response to mRNA SARS-CoV-2 and Nanoparticle Immunization in Mice

2025-10-02

Abstract excerpt

Nanoparticle immunogens excel at rapidly inducing high levels of circulating antibodies and are being deployed as part of several novel vaccines. However, their ability to elicit memory B cell responses is less well understood. Here we compared serologic and memory B cell responses to prime boost vaccination with either SARS-CoV-2 Wuhan-Hu-1 mRNA vaccine, or protein nanoparticles: SARS-CoV-2 B.1.351 homotypic cont...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 70991b5d-e425-5199-bd79-7be493480e74
DOI: 10.1101/2025.10.01.679787

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Memory B cell Development in Response to mRNA SARS-CoV-2 and Nanoparticle Immunization in MiceDOI 10.1101/2025.10.01.679787Read

Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesSemantic proximity Read

Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animalsSemantic proximity Read

Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platformsSemantic proximity Read

Advances in Nanoparticle-Enhanced Vaccine Strategies: Towards a Universal Protection Against Influenza B VirusesSemantic proximity Read

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variantsSemantic proximity Read

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Semantic proximity Read

mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognitionSemantic proximity Read

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsSemantic proximity Read

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.Semantic proximity Read

Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine DoseSemantic proximity Read

The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in miceSemantic proximity Read

Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variantsSemantic proximity Read